Otros idiomas Hana Pharm Co., Ltd.

Acciones

A293480

KR7293480000

Precio de cierre Korea S.E. Otros sitios de cotización 00:00:00 21/05/2024			Varia. Cinco días.	Varia. 1 de enero.
13.010 ^KRW	-1,36 %		-1,81 %	-6,74 %

2023	Las acciones de Singapur vuelven al verde; Hyphens Pharma sube un 5% por un acuerdo para desarrollar un fármaco sedante en Singapur	MT
2023	Hyphens Pharma desarrollará y comercializará en Singapur un fármaco sedante de Hana Pharm	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Singapore Shares Return to Green; Hyphens Pharma Rises 5% on Deal to Develop Sedation Drug in Singapore	18/05/23
Hyphens Pharma to Develop, Commercialize Hana Pharm's Sedation Drug in Singapore	18/05/23
Hyphens Pharma Pte. Ltd. Signs an Exclusive Sub-License and Supply Agreement with Hana Pharm Co., Ltd. to Develop and Commercialise Byfavo® 20mg in Singapore	17/05/23
Eight South Korean Firms to Donate $2.4 Million Worth of Medicine to Ukraine	12/04/22
Hana Pharm Receives Market Approval for Byfavo (Remimazolam) in Procedural Sedation in South Korea	31/08/21
Hana Pharm Informs PAION AG About the Launch of Byfavo™ (Remimazolam) for the Use in General Anesthesia in South Korea	07/04/21
Hana Pharm Co., Ltd's Equity Buyback announced on August 19, 2019, has expired.	18/02/20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on August 6, 2019.	05/02/20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on August 6, 2019.	05/02/20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on August 6, 2019.	05/02/20
Hana Pharm Co., Ltd's Equity Buyback announced on August 6, 2019, has expired with 87,239 shares, representing 0.54% for KRW 1,997.13 million.	05/02/20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on July 9, 2019.	08/01/20
Hana Pharm Co., Ltd's Equity Buyback announced on July 9, 2019, has expired.	08/01/20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on July 26, 2019.	30/10/19
Hana Pharm Co., Ltd's Equity Buyback announced on July 26, 2019, has expired with 84,312 shares, representing 0.53% for KRW 1,997.08 million.	30/10/19
Hana Pharm Co., Ltd announces an Equity Buyback for KRW 1,000 million worth of its shares.	19/08/19
Hana Pharm Co., Ltd authorizes a Buyback Plan.	19/08/19
Hana Pharm Co., Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.	06/08/19
Hana Pharm Co., Ltd authorizes a Buyback Plan.	06/08/19
Hana Pharm Co., Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.	26/07/19

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Hana Pharm Co., Ltd.

Acciones

A293480

KR7293480000

Otros idiomas

Filtros